NervGen Pharma Corp. Common stock (NGEN) vs Protara Therapeutics, Inc. (TARA)
A side-by-side comparison of NervGen Pharma Corp. Common stock and Protara Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NGEN
NervGen Pharma Corp. Common stock
$1.75HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TARA
Protara Therapeutics, Inc.
$2.58HealthcareDelayed quote: Oct 6, 2026, 3:55 PM EDT
Total return — NGEN vs TARA
growth of $100 · dividends reinvested · last 1yNGEN -57.6% (-57.6%/yr)TARA -54.2% (-54.2%/yr)TARA compounded faster over this window
NGEN TARA
NGEN vs TARA: by the numbers
- •TARA is the larger company ($145M vs $144M market cap).
Metrics side by side
Valuation
| Metric | NGEN | TARA |
|---|---|---|
| P/B ratio | 11.81 | 0.90 |
Profitability
| Metric | NGEN | TARA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -397.38% | -43.40% |
| ROIC | -223.90% | -47.18% |
Growth (annualized)
| Metric | NGEN | TARA |
|---|---|---|
| Total return CAGR (5Y) | N/A | -16.45% |
Go deeper
Dig into the metrics
NervGen Pharma Corp. Common stock ROEProtara Therapeutics ROENervGen Pharma Corp. Common stock operating marginProtara Therapeutics operating marginNervGen Pharma Corp. Common stock revenue growthProtara Therapeutics revenue growthNervGen Pharma Corp. Common stock free cash flowProtara Therapeutics free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.